Showing results (71-80 of 181) with videos related to
Sort By:
Pageof 19
Journal of the American Heart Association|January 15, 2013
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjectsJ Michael Gaziano, Anthony H Cincotta, Aaron Vinik, et al.Environmental Science and Pollution Research International|September 2, 2016
Toxic metals and associated sporulated bacteria on Andean hummingbird feathersEsteban Góngora, Carlos Daniel Cadena, Jenny DussánSystematic Biology|September 26, 2017
Issues and Perspectives in Species Delimitation using Phenotypic Data: Atlantean Evolution in Darwin's FinchesCarlos Daniel Cadena, Felipe Zapata, Iván JiménezThe Journal of Biological Chemistry|July 23, 2011
Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiationShaowei Chen, Christine Bellew, Xiao Yao, et al.Current Medical Research and Opinion|September 17, 2015
Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trialsLawrence Blonde, Vincent Woo, Chantal Mathieu, et al.Current Medical Research and Opinion|May 4, 2004
Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort studyLawrence Blonde, George E Dailey, Serge A Jabbour, et al.JMIR Diabetes|June 10, 2021
Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort StudyRichard Milani, Pavan Chava, Jonathan Wilt, et al.Diabetes, Obesity & Metabolism|June 16, 2020
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trialLuigi Meneghini, Lawrence Blonde, Jasvinder Gill, et al.Current Medical Research and Opinion|April 20, 2018
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US populationLawrence Blonde, Chakkarin Burudpakdee, Victoria Divino, et al.The Journal of Clinical Endocrinology and Metabolism|August 2, 2012
Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trialMarcia A Testa, Jasvinder Gill, Max Su, et al.Pageof 19